Pharmaceutical and biotechnology laboratories depend on a wide array of analytical instruments, each operating as an independent data environment with its own file storage, user access controls, and audit trail configurations. Without centralized governance across these decentralized systems, critical compliance gaps can go undetected, creating significant exposure to data integrity findings, costly corrective action, and reputational damage.
In this white paper, Instem experts examine the hidden risks of decentralized laboratory infrastructure and the growing regulatory expectations that organizations must meet. You’ll learn how data fragmentation, limited QA visibility, inconsistent security controls, and incomplete audit trails can prevent laboratories from demonstrating full control over electronic records, and how these gaps can translate into FDA Form 483 observations, CAPA processes, and GMP non-compliance statements with serious financial and reputational consequences.
The paper outlines the regulatory frameworks that govern laboratory data integrity, including 21 CFR Part 11 and the ALCOA and ALCOA+ principles, and explains what compliance requires in practice across instrument-connected environments. Topics include the common vulnerabilities of standalone systems, the limitations of reactive compliance approaches, and the operational and regulatory case for continuous, automated oversight.
You’ll also discover how Instem’s Compliance Builder platform enables laboratories to put these principles into practice. Through automated folder monitoring, configurable electronic signatures, centralized audit trails, desktop telemetry, and real-time alerting, Compliance Builder provides the governance infrastructure needed to maintain inspection readiness with confidence. The paper also highlights the latest enhancements in Compliance Builder 12, including enhanced folder monitoring, temporary user support, improved security controls, and automatic reporting capabilities.
Complete the form to download the full white paper and learn how continuous compliance monitoring can help your laboratory move from reactive remediation to proactive, audit-ready data governance.
